Iambic Therapeutics, Inc., 2025-11-21
An SEC Form D private-offering notice from San Diego, CA, a $124,999,970 filer-stated offering target in Biotech. Filed 2025-11-21. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
AI-driven clinical-stage biotechnology company developing novel medicines using machine learning drug discovery platforms, with an oncology-focused pipeline.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Candlestick Partners MC, LLC, 2025-11-21, $1M, San Francisco, CA
- Atreon Orthopedics LLC, 2025-11-24, Dublin, OH
- Lexe Corp, 2025-11-21, $1M, Foster City, CA
- Kamal Therapeutics, Inc., 2025-11-24, $17.3M, Hingham, MA
- Doppel Inc., 2025-11-21, $61.5M, Covina, CA
- Arpeggio Biosciences, Inc., 2025-11-24, $35.3M, Boulder, CO
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.